Table 2.
Results of cox proportional hazard models.
| Outcomes | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| Original population | HR (95% CIs) | p-value | HR (95% CIs) | p-value | HR (95% CIs) | p-value |
| In-hospital mortality | ||||||
| No-vitamin D | 1.9 (1.4,2.4) | <0.001 | 1.8 (1.4,2.4) | <0.001 | 1.7 (1.3,2.3) | <0.001 |
| Vitamin D | 1 | 1 | 1 | |||
| ICU-mortality | ||||||
| No-vitamin D | 1.8 (1.3,2.6) | 0.001 | 1.7 (1.2,2.5) | 0.003 | 1.8.(1.2,2.6) | 0.003 |
| Vitamin D | 1 | 1 | 1 | |||
| PSM | ||||||
| In-hospital mortality | ||||||
| No-vitamin D | 1.8 (1.3,2.6) | <0.001 | 1.8 (1.3,2.5) | <0.001 | 2.2 (1.5,3.1) | <0.001 |
| Vitamin D | 1 | 1 | 1 | |||
| ICU-mortality | ||||||
| No-vitamin D | 1.9 (1.2,3.0) | 0.004 | 1.9 (1.2,2.9) | 0.006 | 3.1 (1.8,5.3) | <0.001 |
| Vitamin D | 1 | 1 | 1 | |||
Model1 covariates were adjusted for nothing. Model2 covariates were adjusted for age and gender. Model3 covariates were adjusted for age, gender, hematocrit, hemoglobin, platelets, WBC, RBC, anion gap, bicarbonate, BUN, calcium, chloride, creatinine, sodium, potassium, glucose, weight, heart rate, MAP, respiratory rate, temperature, SpO2, INR, PT, RRT, vasopressor use, ventilator use, APS III, OASIS, SOFA, congestive heart failure, myocardial infarction, rheumatic disease, peptic ulcer disease, renal disease, diabetes, malignant cancer, and liver disease.